Join Business Exchange
to access the mostrelevant content for you,
filtered by like-mindedbusiness professionals.
The prices of multiple sclerosis medicines have risen as much as 39 percent since last year, even as competition intensified with the introduction of the first pill to treat the disease. Teva Pharmaceutical Industries...
to access the most relevant content for you, filtered by like-minded business professionals.
About Business Exchange
Send us Feedback
©2013 Bloomberg L.P. All Rights Reserved.